drugset / Trial / NCT04750603
Effect of Fluticasone Furoate/Vilanterol on EIA in Adolescents
RandomizedParallel-groupDouble-blindTreatment
Summary
Exercise induced asthma (EIA) is common in adolescents. (Fluticasone furoate (FF)/Vilanterol (VI)) is a once daily inhaler with bronchodilator effect lasting 24 hours. Our objective was to investigate the short and long-term effects of FF/VI on EIA in adolescents. Adolescent asthmatics were referred for evaluation of EIA. Patients with a positive exercise challenge test, were allocated to a single administration of salbutamol and 22 to FF/VI in a double blind, double dummy method to assess the short-term effect on EIA. Then they received FF/VI for 30-60 days and were reassessed by a repeat exercise test 24-hours after the last dose.
Timeline
- Start
- 2018-12-01
- Primary completion
- 2020-01-31
- Completion
- 2020-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluticasone furoate (FF)/Vilanterol (VI) | Unknown | 22 ug | Inhaled |
| Comparator | Fluticasone furoate (FF)/Vilanterol (VI) | Unknown | 92 ug | Inhaled |
| Comparator | Salbutamol | Unknown | 400 ug | Inhaled |